会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 28. 发明授权
    • Hydroxy-aryl metal chelates for diagnostic NMR imaging
    • 用于诊断NMR成像的羟基 - 芳基金属螯合物
    • US5628982A
    • 1997-05-13
    • US466471
    • 1995-06-06
    • Randall B. LaufferScott K. Larsen
    • Randall B. LaufferScott K. Larsen
    • A61K49/06A61K49/00
    • A61K49/06Y10T436/24
    • An NMR contrast agent composition contains a complex of a selected metal ion and a selected ligand. The ion is selected from the group consisting of gadolinium (III), iron (III), manganese (II), manganese (III), chromium (III), copper (II), dysprosium (III), terbium (III), holmium (III), erbium (III), europium (II), and europium (III); and the ligand is a linear two-nitrogen compound having one 2-hydroxy-aryl group at one of the nitrogen; or the ligand is a linear two-nitrogen compound having one or two 2-hydroxy-aryl groups at each of the nitrogens; or the ligand is a linear three-, four-, or five-nitrogen compound having one or two 2-hydroxy-aryl substituents at each of one or more of the nitrogens, or the ligand is a heterocyclic compound having a ring containing three or four nitrogens, and having a 2-hydroxy-aryl substitent at one or more of the nitrogens; or the ligand is a heterocyclic compound having a ring containing 4 nitrogens, and having a carboxyl group at two of the nitrogens and an aromatic substituent at the other two of the nitrogens. Also, a method for enhancing the contrast in NMR imaging in a patient includes steps of preparing an NMR contrast enhancing agent by mixing an NMR contrast compound of the invention with a pharmaceutically acceptable carrier, introducing the NMR contrast enhancing agent into the patient, and subjecting the patient to NMR imaging.
    • NMR造影剂组合物含有所选择的金属离子和所选择的配体的络合物。 离子选自钆(III),铁(III),锰(II),锰(III),铬(III),铜(II),镝(III),铽(III),钬 (III),铒(III),铕(II)和铕(III); 并且配体是在一个氮气下具有一个2-羟基 - 芳基的直链二氮化合物; 或者配体是在每个氮原子上具有一个或两个2-羟基 - 芳基的线性二氮化合物; 或者配体是在一个或多个氮的每一个上具有一个或两个2-羟基 - 芳基取代基的线性三,四或五氮化合物,或者配体是具有环的三价或 四个氮,并且在一个或多个氮上具有2-羟基 - 芳基取代基; 或者配体是具有含有4个氮的环的杂环化合物,并且在两个氮原子处具有羧基,在另外两个氮原子具有芳香族取代基。 此外,用于增强患者的NMR成像中的对比度的方法包括通过将本发明的NMR对比化合物与药学上可接受的载体混合来制备NMR对比度增强剂的步骤,将NMR对比度增强剂引入患者体内, 患者以NMR成像。
    • 30. 发明授权
    • Hydroxy-aryl metal chelates for diagnostic NMR imaging
    • 用于诊断NMR成像的羟基 - 芳基金属螯合物
    • US5527522A
    • 1996-06-18
    • US397892
    • 1995-03-03
    • Randall B. LaufferScott K. Larsen
    • Randall B. LaufferScott K. Larsen
    • A61K49/06A61K49/00A61B6/00
    • A61K49/06Y10T436/24
    • An NMR contrast agent composition contains a complex of a selected metal ion and a selected ligand. The ion is selected from the group consisting of gadolinium (III), iron (III), manganese (II), manganese (III), chromium (III), copper (II), dysprosium (III), terbium (III), holmium (III), erbium (III), europium (II), and europium (III); and the ligand is a linear two-nitrogen compound having one 2-hydroxy-aryl group at one of the nitrogens: or the ligand is a linear two-nitrogen compound having one or two 2-hydroxy-aryl groups at each of the nitrogens; or the ligand is a linear three-, four-, or five-nitrogen compound having one or two 2-hydroxy-aryl substituents at each of one or more of the nitrogens, or the ligand is a heterocyclic compound having a ring containing three or four nitrogens, and having a 2-hydroxy-aryl substitent at one or more of the nitrogens; or the ligand is a heterocyclic compound having a ring containing 4 nitrogens, and having a carboxyl group at two of the nitrogens and an aromatic substituent at the other two of the nitrogens.
    • NMR造影剂组合物含有所选择的金属离子和所选择的配体的络合物。 离子选自钆(III),铁(III),锰(II),锰(III),铬(III),铜(II),镝(III),铽(III),钬 (III),铒(III),铕(II)和铕(III); 并且该配位体是在一个氮原子上具有一个2-羟基 - 芳基的直链二氮化合物:或配位体是在每个氮原子上具有一个或两个2-羟基 - 芳基的直链二氮化合物; 或者配体是在一个或多个氮的每一个上具有一个或两个2-羟基 - 芳基取代基的线性三,四或五氮化合物,或者配体是具有环的三价或 四个氮,并且在一个或多个氮上具有2-羟基 - 芳基取代基; 或者配体是具有含有4个氮的环的杂环化合物,并且在两个氮原子处具有羧基,在另外两个氮原子具有芳香族取代基。